Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabrina Rossi

Showing results (171-180 of 186) with videos related to

Pageof 19
Sort By:
Therapeutic Advances in Medical Oncology|January 22, 2024
Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registryBruno Vincenzi, Alessio Cortellini, Alessandro Mazzocca, et al.
European Journal of Cancer (Oxford, England : 1990)|March 30, 2020
First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance statusFrancesco Facchinetti, Giulia Mazzaschi, Fausto Barbieri, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 29, 2023
Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registryAnahita Mostaghim, Samuel Minkove, Juan Aguilar-Company, et al.
Cancer Treatment and Research Communications|February 26, 2026
Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational studyPaolo Bironzo, Alessandro Morabito, Sonia Silipigni, et al.
European Urology|December 24, 2025
RESECT: A Randomised Controlled Trial of Audit and Feedback in Non-muscle-invasive Bladder Cancer SurgeryKevin Gallagher, Steven MacLennan, Nikita Bhatt, et al.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2022
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancerDavid J Pinato, Daniela Ferrante, Juan Aguilar-Company, et al.
Lung Cancer (Amsterdam, Netherlands)|November 1, 2020
Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY studyMelissa Bersanelli, Sebastiano Buti, Diana Giannarelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2023
Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast CancerMarco Tagliamento, Alessandra Gennari, Matteo Lambertini, et al.
ESMO Open|August 30, 2017
Clinical activity and tolerability of FOLFIRI and cetuximab in elderly patients with metastatic colorectal cancer in the CAPRI-GOIM first-line trialE Martinelli, C Cardone, T Troiani, et al.
The Lancet. Oncology|June 6, 2022
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry studyDavid J Pinato, Juan Aguilar-Company, Daniela Ferrante, et al.
Pageof 19

Showing results (171-180 of 186) with videos related to

Sort By:
Pageof 19
Therapeutic Advances in Medical Oncology|January 22, 2024
Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registryBruno Vincenzi, Alessio Cortellini, Alessandro Mazzocca, et al.
European Journal of Cancer (Oxford, England : 1990)|March 30, 2020
First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance statusFrancesco Facchinetti, Giulia Mazzaschi, Fausto Barbieri, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 29, 2023
Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registryAnahita Mostaghim, Samuel Minkove, Juan Aguilar-Company, et al.
Cancer Treatment and Research Communications|February 26, 2026
Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational studyPaolo Bironzo, Alessandro Morabito, Sonia Silipigni, et al.
European Urology|December 24, 2025
RESECT: A Randomised Controlled Trial of Audit and Feedback in Non-muscle-invasive Bladder Cancer SurgeryKevin Gallagher, Steven MacLennan, Nikita Bhatt, et al.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2022
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancerDavid J Pinato, Daniela Ferrante, Juan Aguilar-Company, et al.
Lung Cancer (Amsterdam, Netherlands)|November 1, 2020
Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY studyMelissa Bersanelli, Sebastiano Buti, Diana Giannarelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2023
Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast CancerMarco Tagliamento, Alessandra Gennari, Matteo Lambertini, et al.
ESMO Open|August 30, 2017
Clinical activity and tolerability of FOLFIRI and cetuximab in elderly patients with metastatic colorectal cancer in the CAPRI-GOIM first-line trialE Martinelli, C Cardone, T Troiani, et al.
The Lancet. Oncology|June 6, 2022
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry studyDavid J Pinato, Juan Aguilar-Company, Daniela Ferrante, et al.
Pageof 19